LRRC19 | Leucine rich repeat containing 19 | Predicted membrane proteins
| | | | | Tissue enhanced |
TEK | TEK tyrosine kinase, endothelial | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Mixed |
EQTN | Equatorin, sperm acrosome associated | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
MOB3B | MOB kinase activator 3B | | | | | | Mixed |
IFNK | Interferon, kappa | | | | | | Not detected |
C9orf72 | Chromosome 9 open reading frame 72 | Disease related genes
| | | | | Expressed in all |
LINGO2 | Leucine rich repeat and Ig domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
ACO1 | Aconitase 1, soluble | Cancer-related genes Citric acid cycle related proteins Enzymes Plasma proteins
| | | | | Expressed in all |
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | Enzymes
| | | | | Expressed in all |
TOPORS | Topoisomerase I binding, arginine/serine-rich, E3 ubiquitin protein ligase | Disease related genes
| | | | | Expressed in all |
NDUFB6 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
GVQW1 | GVQW motif containing 1 | Predicted secreted proteins
| | | | | Mixed |
TAF1L | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 210kDa-like | Plasma proteins
| | | | | Mixed |
TMEM215 | Transmembrane protein 215 | Predicted membrane proteins
| | | | | Group enriched |
APTX | Aprataxin | Disease related genes
| | | | | Expressed in all |
DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | | | | | | Expressed in all |
SMU1 | Smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) | | | | | | Expressed in all |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
SPINK4 | Serine peptidase inhibitor, Kazal type 4 | Predicted secreted proteins
| | | | | Group enriched |
BAG1 | BCL2-associated athanogene | Cancer-related genes
| | | | | Expressed in all |
CHMP5 | Charged multivesicular body protein 5 | Plasma proteins
| | | | | Expressed in all |
NFX1 | Nuclear transcription factor, X-box binding 1 | Plasma proteins Transcription factors
| | | | | Expressed in all |
AQP7 | Aquaporin 7 | Predicted membrane proteins
| | | | | Tissue enhanced |
AQP3 | Aquaporin 3 (Gill blood group) | Blood group antigen proteins Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NOL6 | Nucleolar protein 6 (RNA-associated) | Predicted membrane proteins
| | | | | Expressed in all |
ANKRD18B | Ankyrin repeat domain 18B | | | | | | Tissue enhanced |
PRSS3 | Protease, serine, 3 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
UBE2R2 | Ubiquitin-conjugating enzyme E2R 2 | Enzymes
| | | | | Expressed in all |
UBAP2 | Ubiquitin associated protein 2 | Predicted secreted proteins
| | | | | Expressed in all |
DCAF12 | DDB1 and CUL4 associated factor 12 | | | | | | Expressed in all |
UBAP1 | Ubiquitin associated protein 1 | | | | | | Expressed in all |
KIF24 | Kinesin family member 24 | | | | | | Tissue enhanced |
NUDT2 | Nudix (nucleoside diphosphate linked moiety X)-type motif 2 | Enzymes
| | | | | Expressed in all |
KIAA1161 | KIAA1161 | | | | | | Mixed |
C9orf24 | Chromosome 9 open reading frame 24 | | | | | | Group enriched |
FAM219A | Family with sequence similarity 219, member A | | | | | | Expressed in all |
DNAI1 | Dynein, axonemal, intermediate chain 1 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ENHO | Energy homeostasis associated | Predicted secreted proteins
| | | | | Tissue enriched |
CNTFR | Ciliary neurotrophic factor receptor | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RPP25L | Ribonuclease P/MRP 25kDa subunit-like | | | | | | Expressed in all |
DCTN3 | Dynactin 3 (p22) | | | | | | Expressed in all |
ARID3C | AT rich interactive domain 3C (BRIGHT-like) | Transcription factors
| | | | | Tissue enriched |
SIGMAR1 | Sigma non-opioid intracellular receptor 1 | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
GALT | Galactose-1-phosphate uridylyltransferase | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
GALT | Uncharacterized protein | | | | | | Not detected |
IL11RA | Interleukin 11 receptor, alpha | Disease related genes FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CCL27 | Chemokine (C-C motif) ligand 27 | Predicted secreted proteins
| | | | | Tissue enriched |
RP11-195F19.5 | HCG2040265, isoform CRA_a; Uncharacterized protein; cDNA FLJ50015 | | | | | | Tissue enriched |
CCL19 | Chemokine (C-C motif) ligand 19 | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CCL21 | Chemokine (C-C motif) ligand 21 | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |